Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase InhibitorsAna M. Metelo, Reuben Benjamin, Charlotte Graham et al.|Cancer Research Communications|2022Cited by 39
Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-GroupsAna M. Metelo, Reuben Benjamin, Ieuan Walker et al.|Blood|2019Cited by 3